168 related articles for article (PubMed ID: 2794937)
1. Medical dissolution of gallstones by ursodeoxycholic acid: a clinical trial on 14 patients.
Lin JT; Wang JT; Wang TH; Su CT
Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):370-6. PubMed ID: 2794937
[TBL] [Abstract][Full Text] [Related]
2. [Dissolution of gallstones based on 6 months treatment with a single daily dose of ursodeoxycholic acid].
Realini S; Gonvers JJ; Arnold J; Borel GA; Bretholz A; Capitaine Y; Hofstetter JR; Bettini L; di Simone A
Schweiz Med Wochenschr; 1983 Apr; 113(17):641-2. PubMed ID: 6867654
[TBL] [Abstract][Full Text] [Related]
3. Final outcome of ursodeoxycholic acid treatment in 126 patients with radiolucent gallstones.
Gleeson D; Ruppin DC; Saunders A; Murphy GM; Dowling RH
Q J Med; 1990 Jul; 76(279):711-29. PubMed ID: 2217675
[TBL] [Abstract][Full Text] [Related]
4. Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution.
Iwamura K
Hepatogastroenterology; 1980 Feb; 27(1):26-34. PubMed ID: 7203354
[TBL] [Abstract][Full Text] [Related]
5. Franco-Belgian cooperative study of ursodeoxycholic acid in the medical dissolution of gallstones: a double-blind, randomized, dose-response study, and comparison with chenodeoxycholic acid.
Erlinger S; Le Go A; Husson JM; Fevery J
Hepatology; 1984; 4(2):308-14. PubMed ID: 6706305
[TBL] [Abstract][Full Text] [Related]
6. Treatment of radiolucent gallstones with CDCA or UDCA. A multicenter trial.
Polli EE; Bianchi PA; Conte D; Sironi L
Digestion; 1981; 22(4):185-91. PubMed ID: 7030835
[TBL] [Abstract][Full Text] [Related]
7. Gallstone dissolution after 6 months of ursodeoxycholic acid (UDCA): effectiveness of different doses.
Podda M; Zuin M; Carulli N; Ponz de Leon M; Dioguardi ML
J Int Med Res; 1982; 10(1):59-63. PubMed ID: 7060825
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Tokyo Cooperative Gallstone Study Group.
Gastroenterology; 1980 Mar; 78(3):542-8. PubMed ID: 6985882
[TBL] [Abstract][Full Text] [Related]
10. Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.
Meredith TJ; Williams GV; Maton PN; Murphy GM; Saxton HM; Dowling RH
Gut; 1982 May; 23(5):382-9. PubMed ID: 7076015
[TBL] [Abstract][Full Text] [Related]
11. Effect of diet on dissolution of gallstones by ursodeoxycholic acid, including a comparison between ultrasonography and cholecystography.
Lefkof IR; Frenkiel PG; Lee DW; Cohen H; Bonorris GG; Gilmore CJ; Hamlin JA; Komaiko M; Resser K; Marks JW
Mt Sinai J Med; 1986 Apr; 53(4):241-9. PubMed ID: 3014318
[No Abstract] [Full Text] [Related]
12. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
Leiss O; von Bergmann K
Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
[TBL] [Abstract][Full Text] [Related]
13. Oral dissolution therapy for cholelithiasis: mix and match.
Phillips RS; Barkin JS
Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
[TBL] [Abstract][Full Text] [Related]
14. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
Iwamura K
Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
[TBL] [Abstract][Full Text] [Related]
15. The present status of agents for dissolving gallstones.
Tangedahl T
Am J Gastroenterol; 1985 Jan; 80(1):64-6. PubMed ID: 3881015
[TBL] [Abstract][Full Text] [Related]
16. [Multicenter study on the litholytic effect of ursodeoxycholic acid. 30 cases].
Voirol M; Stalder GA; Fasel J; Séchaud R; Desbaillets LG; Kapp F; Krieg P; Aenishänslin HW; Wyss G
Schweiz Med Wochenschr; 1983 Apr; 113(17):643-5. PubMed ID: 6346484
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.
Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1984 Feb; 27(2):95-131. PubMed ID: 6365507
[TBL] [Abstract][Full Text] [Related]
18. Treatment of gallstones with chenodeoxy-and ursodeoxycholic acid; the influence of presence or absence of hyperlipidemia on gallstone dissolution.
Kajiyama G; Maruhashi A; Mizuno T; Yamada K; Kawamoto T; Fujiyama M; Kubota S; Sasaki H; Oyamada K; Nakao S; Miyoshi A
Hiroshima J Med Sci; 1979 Jun; 28(2):67-71. PubMed ID: 478985
[No Abstract] [Full Text] [Related]
19. Radiolucent gallstone dissolution with bedtime UDCA administration.
Conte D; Bozzani A; Sironi L; Rocca F; Camassa L; Bianchi PA
Digestion; 1981; 22(6):302-4. PubMed ID: 7333417
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones.
Tint GS; Salen G; Colalillo A; Graber D; Verga D; Speck J; Shefer S
Ann Intern Med; 1982 Sep; 97(3):351-6. PubMed ID: 7051912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
